Zobrazeno 1 - 10
of 147
pro vyhledávání: '"F. Casadebaig"'
Autor:
F. Casadebaig, I. Durand-Zaleski, A. Mehnert, Pierre-Michel Llorca, L.F. Omnès, P Guillon, G Jasso-Mosqueda, H Miadi-Fargier, Christophe Lançon, A. Philippe, A. Chicoye
Publikováno v:
L'Encéphale. 31:235-246
Resume La schizophrenie est une maladie chronique qui necessite un traitement au long cours. La continuite du traitement est un element cle de la prise en charge permettant une reduction du nombre de rechutes et du nombre de re-hospitalisations. Les
Publikováno v:
L'Encéphale. 30:46-51
Resume Les deux coupes transversales dont les resultats sont analyses ici s’interessent a la pharmaco-epidemiologie des pratiques de prescriptions des antipsychotiques. Elles ont ete realisees en 1995 et en 1998 dans le service public de psychiatri
Publikováno v:
European psychiatry (Ed. Española). 5:102-107
ResumenEste estudio se ocupa del estado de salud física y la disponibilidad de asistencia somática para 3.470 pacientes adultos diagnosticados de esquizofrenia según los criterios de investigación establecidos por la Clasificatión Internacional
Publikováno v:
European Psychiatry. 12:289-293
SummaryThis study concerns the state of physical health and the availability of somatic care for 3,470 adult patients diagnosed as schizophrenic according to the research criteria established by the International Classification of Diseases (ICD-10 F2
Publikováno v:
Journal of Heterocyclic Chemistry. 28:391-395
The concerted use of the 1 H/ 13 C shift correlation with 1 H/ 1 H decoupling and the modified COLOC sequence for long-range X/H correlation 2D nmr spectroscopy allows the total assignement of the 13 C nmr resonances of 1,2,3,4-tetrahydroquinazoline
Autor:
Nicole Quemada, F. Casadebaig
Publikováno v:
Social Psychiatry and Psychiatric Epidemiology. 26:78-82
Data based on a national classification of mental disorders were collected continuously between 1968 and 1976, and then every two years from 1976 to 1982, following the same standards, in French public sector psychiatric hospitals. It was possible to
Publikováno v:
European Psychiatry
European Psychiatry, Cambridge University press, 2005, 20 Suppl 4, pp.S340-4
European Psychiatry, 2005, 20 Suppl 4, pp.S340-4
European Psychiatry, Cambridge University press, 2005, 20 Suppl 4, pp.S340-4
European Psychiatry, 2005, 20 Suppl 4, pp.S340-4
To establish the impact of antipsychotic medication on the incidence of diabetes, we have analysed data from the prospective French Cohort study of mortality in schizophrenia. This generated a large database of 3470 patients with schizophrenia initia
Autor:
Bruno Falissard, Sylvie Ledoux, Isabelle Gasquet, F. Casadebaig, Michael Lukasiewicz, A. Philippe, Michel Reynaud
Publikováno v:
Pharmacoepidemiology and drug safety. 15(8)
Background Anti-psychotic prescription in schizophrenia is characterised in Europe by frequent associations and high doses. Nevertheless, few longitudinal epidemiological studies have explored anti-psychotic prescriptions. Aim (1) To describe the evo
Autor:
P M, Llorca, H, Miadi-Fargier, C, Lançon, G, Jasso Mosqueda, F, Casadebaig, A, Philippe, P, Guillon, A, Mehnert, L F, Omnès, A, Chicoye, I, Durand-Zaleski
Publikováno v:
L'Encephale. 31(2)
Schizophrenia is a disease affecting the young adults and amounts to approximately 300,000 people in France. The French public psychiatric sector takes care of approximately 150,000 adults schizophrenics: 50% benefit from ambulatory care, 50% are in
Publikováno v:
L'Encephale. 30(1)
The two cross-sectional surveys reported here concern the field of pharmaco-epidemiology of prescription practices. The objective is to describe and understand these practices in regard to antipsychotics and their evolution in all indications which g